InTrack Investment Management Inc Acquires Shares of 4,255 iShares Biotechnology ETF (NASDAQ:IBB)

InTrack Investment Management Inc acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the first quarter, Holdings Channel.com reports. The institutional investor acquired 4,255 shares of the financial services provider’s stock, valued at approximately $584,000.

A number of other large investors have also added to or reduced their stakes in the stock. State of Michigan Retirement System bought a new stake in shares of iShares Biotechnology ETF in the first quarter valued at $6,861,000. Penbrook Management LLC increased its holdings in iShares Biotechnology ETF by 2.3% in the 1st quarter. Penbrook Management LLC now owns 4,050 shares of the financial services provider’s stock worth $556,000 after acquiring an additional 90 shares during the last quarter. Miracle Mile Advisors LLC raised its stake in iShares Biotechnology ETF by 1.3% in the 1st quarter. Miracle Mile Advisors LLC now owns 24,854 shares of the financial services provider’s stock valued at $3,410,000 after acquiring an additional 308 shares during the period. Mirador Capital Partners LP lifted its holdings in iShares Biotechnology ETF by 3.1% during the first quarter. Mirador Capital Partners LP now owns 28,833 shares of the financial services provider’s stock valued at $3,956,000 after purchasing an additional 860 shares during the last quarter. Finally, Chapin Davis Inc. bought a new position in iShares Biotechnology ETF during the first quarter worth about $215,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB traded down $0.95 during trading hours on Tuesday, hitting $136.02. The company’s stock had a trading volume of 1,272,023 shares, compared to its average volume of 1,636,634. The business has a 50 day simple moving average of $134.64 and a two-hundred day simple moving average of $134.94. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $141.16.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.